We are live on
!
Find out more
HCP
Holt Capital Partners Portfolio holdings
AUM
$742M
1-Year Est. Return
18.42%
This Fund
S&P 500
This Quarter
Est. Return
+14.68%
1 Year Est. Return
+18.42%
3 Year Est. Return
+55.2%
5 Year Est. Return
+62.5%
10 Year Est. Return
+193.17%
AUM
$442M
AUM Growth
+$59.4M
(+16%)
Cap. Flow
+$6.52M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
45.57%
Holding
158
New
15
Increased
67
Reduced
38
Closed
4
Top Buys
Top Sells
Sector Composition
| 1 | Financials | 5.93% |
| 2 | Technology | 5.71% |
| 3 | Healthcare | 3.92% |
| 4 | Industrials | 2.51% |
| 5 | Communication Services | 2.07% |
Similar funds
AFG
APG
EIG
KAM
SIA
ROC
HI
CAWM
Holt Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Holt Capital Partners held 158 positions worth $442M, up 16% from $382M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Holt Capital Partners's Q4 2020 filing shows 15 new, 67 increased, 38 reduced and 4 closed positions. Its largest new stake was Waters Corp: 1,139 shares worth $282K. The largest sale was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF, an estimated $822K.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, up from 5.5% a quarter earlier, followed by Technology and Healthcare.
- Holt Capital Partners's largest Q4 2020 buy was Waters Corp: 1,139 shares worth $282K.
- Holt Capital Partners added most to iShares MSCI USA Quality Factor ETF in Q4 2020, an estimated $1.85M increase.
- Holt Capital Partners's biggest Q4 2020 reduction was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF, cutting an estimated $822K.
- Holt Capital Partners fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $408K.
- Holt Capital Partners's ten largest holdings make up 46% of its $442M portfolio in Q4 2020.
- Holt Capital Partners opened 15 new positions and closed 4 in Q4 2020.
- Holt Capital Partners's portfolio value rose 16% quarter-over-quarter to $442M.
Based on Holt Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.